| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 01/03/2013 | 14h49 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/02/2013 | 19h02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 16h02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 16h02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 12h08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/02/2013 | 12h08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/02/2013 | 14h07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/02/2013 | 14h03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 05/02/2013 | 15h01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 24/01/2013 | 21h51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 23/01/2013 | 23h26 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/01/2013 | 14h06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 14/01/2013 | 14h06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 21h33 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 21h33 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 21h33 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 08/01/2013 | 19h40 | Zacks | Repligen, Pfizer Collaborate - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 07/01/2013 | 16h24 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 07/01/2013 | 16h24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 04/01/2013 | 19h16 | Zacks | BioMimetic's Pipeline Progresses - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 23h10 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 23h10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 23h08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 23h08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 15h00 | Business Wire | BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 03/01/2013 | 09h14 | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 12h03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 12h03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 12h03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 26/12/2012 | 12h03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |